- Enrollment
- 33
- Started
- Jul 2012
- Completion
- Dec 2012
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2012
Industry sponsor intelligence
HLB Pharmaceutical Co., Ltd.Clinical Pipeline.
Lead-sponsor view of HLB Pharmaceutical Co., Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 0
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 33
Pipeline overview
Programs by phase and activity.
Velocity
HLB Pharmaceutical Co., Ltd. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 11
Phase 20
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Bivalirudin → | 1 | 1 | 0 | 0 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All HLB Pharmaceutical Co., Ltd. studies.
This page groups studies where HLB Pharmaceutical Co., Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates